We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PCE/Core PCE Inflation In Line With Estimates in June
Read MoreHide Full Article
It’s been an eventful week in the markets. And this morning, we have arguably the most substantial numbers of all: Personal Consumption Expenditures (PCE) for June, the Fed’s preferred measure of inflation. Both headline figures came in-line with estimates: +0.1% month over month and +2.5% year over year, up +10 basis points (bps) on the former and -10 bps on the latter. Pre-market futures are jumping this morning, though this may have to do with favorable market conditions after the sell-off mid-week.
Importantly, this yearly figure goes back to where we started 2024. (PCE numbers were among those keeping the Fed on the sidelines in its previous opportunities to cut interest rates.) Before that, we’d have to go back three-and-a-half years — to February 2021 — in order to see a lower full-year PCE rate. Core (subtracting volatile food and energy prices) month over month was also in-line with estimates, as was core year-over-year’s +2.6% — matching the previous month and the lowest since March 2021.
Personal Income came in at only half expectations: +0.2% versus +0.4%, the lightest number since October of last year. It’s also half the downwardly revised +0.4% for May. Personal Spending was in-line with estimates at +0.3%, but the previous month revised twice as high, from +0.2% to +0.4%. Real Spending came in at +0.2%, again from an upwardly revised +0.4% in May. The Savings Rate notched down to +3.4% from +3.5%.
This is a fine report for the Fed’s purposes. Inflation does seem to remain well-behaved on spending/consumption, although for those market participants still pining for a July rate cut, you can pretty much put that to rest. Yesterday’s higher Q2 GDP headline — although the upward surprise was at least partly the result of higher inventories, sort of the “junk food” of economic growth — affords the Fed until September to begin bringing down interest rates.
Q2 earnings reports continue to flow in. Industrial conglomerate 3M (MMM - Free Report) beat earnings per share estimates by +16.27%, as well as a +6.3% positive surprise on the top line. Shares are up +6.4% at this hour, on a strong pre-market pretty much across the board.
Bristol Myers-Squibb (BMY - Free Report) also posted a nice quarter. At earnings of $2.07 per share, it beat the $1.64 Zacks consensus by +26%, with $12.2 billion in revenues amounting to a +6% beat. Shares are up +7% in early trading.
Colgate Palmolive (CL - Free Report) has more modest results, but still beat. It surpassed earnings per share estimates by +4.6% on +0.93% higher revenues. Shares are up +1.5% ahead of the opening bell.
T. Rowe Price (TROW - Free Report) posted a mixed quarter. While beating earnings estimates by a penny — $2.26 versus $2.25 — the global asset management firm brought in revenues of $1.73 billion, -3% from estimates.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
PCE/Core PCE Inflation In Line With Estimates in June
It’s been an eventful week in the markets. And this morning, we have arguably the most substantial numbers of all: Personal Consumption Expenditures (PCE) for June, the Fed’s preferred measure of inflation. Both headline figures came in-line with estimates: +0.1% month over month and +2.5% year over year, up +10 basis points (bps) on the former and -10 bps on the latter. Pre-market futures are jumping this morning, though this may have to do with favorable market conditions after the sell-off mid-week.
Importantly, this yearly figure goes back to where we started 2024. (PCE numbers were among those keeping the Fed on the sidelines in its previous opportunities to cut interest rates.) Before that, we’d have to go back three-and-a-half years — to February 2021 — in order to see a lower full-year PCE rate. Core (subtracting volatile food and energy prices) month over month was also in-line with estimates, as was core year-over-year’s +2.6% — matching the previous month and the lowest since March 2021.
Personal Income came in at only half expectations: +0.2% versus +0.4%, the lightest number since October of last year. It’s also half the downwardly revised +0.4% for May. Personal Spending was in-line with estimates at +0.3%, but the previous month revised twice as high, from +0.2% to +0.4%. Real Spending came in at +0.2%, again from an upwardly revised +0.4% in May. The Savings Rate notched down to +3.4% from +3.5%.
This is a fine report for the Fed’s purposes. Inflation does seem to remain well-behaved on spending/consumption, although for those market participants still pining for a July rate cut, you can pretty much put that to rest. Yesterday’s higher Q2 GDP headline — although the upward surprise was at least partly the result of higher inventories, sort of the “junk food” of economic growth — affords the Fed until September to begin bringing down interest rates.
Q2 earnings reports continue to flow in. Industrial conglomerate 3M (MMM - Free Report) beat earnings per share estimates by +16.27%, as well as a +6.3% positive surprise on the top line. Shares are up +6.4% at this hour, on a strong pre-market pretty much across the board.
Bristol Myers-Squibb (BMY - Free Report) also posted a nice quarter. At earnings of $2.07 per share, it beat the $1.64 Zacks consensus by +26%, with $12.2 billion in revenues amounting to a +6% beat. Shares are up +7% in early trading.
Colgate Palmolive (CL - Free Report) has more modest results, but still beat. It surpassed earnings per share estimates by +4.6% on +0.93% higher revenues. Shares are up +1.5% ahead of the opening bell.
T. Rowe Price (TROW - Free Report) posted a mixed quarter. While beating earnings estimates by a penny — $2.26 versus $2.25 — the global asset management firm brought in revenues of $1.73 billion, -3% from estimates.